IJCEMR
Clinical Efficacy of Clinical Nerve Intervention in the Treatment of Cerebrovascular Diseases
TOTAL VIEWS: 7966
Abstract
Objective: To explore the clinical efficacy of clinical nerve intervention in the treatment of cerebrovascular diseases. Methods: 72 cases of patients with cerebrovascular disease in our hospital from June 2019 to June 2020 were randomly divided into observation group and control group, 36 cases in each group. The patients in the observation group were treated with clinical nerve intervention, while those in the control group were treated by craniotomy. The quality of life, complications, recurrences and improvement of arterial blood vessels were compared and analyzed. Results: The total incidence of compli-cations in the observation group 0 cases (0.00%) was significantly lower than the control group 6 cases (16.67%), the improvement rate of arterial thrombosis in the observation group 33 cases (91.67%) was significantly higher than the control group 26 cases (72.22%), the recurrence rate of the observation group 0 cases (0.00%) was significantly lower than the control group 7 cases (19.44%), the differences were statistically significant (P < 0.05). The scores of quality of life (QOL) of meeting, body, environment, psychology and com-prehensive in the observation group were significantly higher than the control group (P < 0.05). Conclusion: For patients with cerebrovascular disease, clinical nerve intervention therapy can significantly improve the quality of life of patients, reduce the recurrence rate of disease, improve the patients' arterial blood vessels, reduce the incidence of complications, it is safe and effective, with clinical application value.
References
[1] Zuereai, Yahefu, Dang Hui, Wang Chengfeng, et al. (2018). Short term and long-term clinical effects of Neurointerventional therapy for ischemic cerebrovascular disease [J]. Chinese Medical Guide, 2018, 15(7): 70-73.
[2] Fan Lingyun, Suo Xiaoyan. (2020). Effect of interventional nursing on cerebrovascular interventional therapy and nursing sa-tisfaction [J]. Shanxi Medical Journal, 2020, 49(5): 627-629.
[3] Liu Guojing. (2020). Clinical efficacy of interventional stenting for ischemic cerebrovascular disease [J]. Chinese Journal of Medicine and Clinical, 2020, 20(8): 1334-1335.
[4] Zhang Xiaolan. (2018). Application value of quality control theory in nursing care of patients with acute cerebrovascular disease undergoing interventional therapy [J]. Journal of Practical Cardio Cerebrovascular Disease, 2018, 26 (z1): 353-355.
[5] Zhou Weiping. (2018). Influence of humanistic care on patients with intracranial aneurysm undergoing interventional therapy [J]. Beijing Medical Journal, 2018, 40(7): 711-712.
[6] Lu zygang, Wang Lina, Chen Xiaohui, et al. (2018). Effects of contrast media on renal function in patients with cerebrovascular disease and diabetes mellitus after interventional therapy [J]. Journal of Interventional Radiology, 2018, 27(3): 277-280.
[7] AmanPreet Badhwar, Rebecca Brown, Danica B Stanimirovic, etal. (2017). Proteomic differences in brain vessels of Alzheimer’s disease mice: Normalization by PPARγ agonist pioglitazone [J]. J Cereb Blood Flow Metab., 2017, 37(3): 1120-1136.
[8] Manus J Donahue, Eric Achten, Petrice M Cogswell, et al. Consensus statement on current and emerging methods for the di-agnosis and evaluation of cerebrovascular disease [J]. J Cereb Blood Flow Metab., 2018, 38(9): 1391-1417.
[9] Liping Liu, Weiqi Chen, Hongyu Zhou, et al. (2020). Chinese Stroke Association guidelines for clinical management of cere-brovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases [J]. Stroke Vasc Neurol., 2020, 5(2): 159-176.
[10] Shih-Wei Lai, Hsien-Feng Lin, Cheng-Li Lin, et al. (2016). Long-term effects of pioglitazone on first attack of ischemic cere-brovascular disease in older people with type 2 diabetes: A case-control study in Taiwan [J]. Medicine (Baltimore), 2016, 95(31): 4455.
[11] Christoph J Griessenauer, Sean Farrell, Atom Sarkar, et al. (2018). Genetic susceptibility to cerebrovascular disease: A systematic review [J]. J Cereb Blood Flow Metab., 2018, 38(11): 1853-1871.
[12] Eliza C. Miller. (2019). Preeclampsia and Cerebrovascular Disease: The Maternal Brain at Risk [J]. Hypertension, 2019, 74(1): 5-13.
[13] Tuck-Siu Wong, Kuan-Fu Liao, Chi-Ming Lin, et al. (2016). Chronic Pancreatitis Correlates With Increased Risk of Cerebro-vascular Disease: A Retrospective Population-Based Cohort Study in Taiwan [J]. Medicine (Baltimore), 2016, 95(15): 3266.
[14] Mark J Alberts, Jean Range, William Spencer, et al. (2017). Availability of endovascular therapies for cerebrovascular disease at primary stroke centers [J]. Interv Neuroradiol, 2017, 23(1): 64-68.
[15] Shu-Wen Mu, Yuan Dang, Shou-Sen Wang, et al. (2018). The role of high mobility group box 1 protein in acute cerebrovascular diseases [J]. Biomed Rep., 2018, 9(3): 191-197.
How to cite this paper
Clinical Efficacy of Clinical Nerve Intervention in the Treatment of Cerebrovascular Diseases
How to cite this paper: Xiansong Cheng, Huanhuan Li, Junqing Gao, Wei Di, Hua Lv. (2020) Clinical Efficacy of Clinical Nerve Intervention in the Treatment of Cerebrovascular Diseases. International Journal of Clinical and Experimental Medicine Research, 4(4), 190-193.
DOI: http://dx.doi.org/10.26855/ijcemr.2020.10.012
More Articles
- A Meta-analysis of Tianma Gouteng Decoction Combined with Qiju Dihuang Pills in the Treatment of Essential Hypertension
- Advances in Microecological Agents and Traditional Chinese Medicine in Reversing Cirrhosis
- A Qualitative Study on the Inner Feelings and Needs of Medical Students during the Closure Period
- Theoretical Discussion on the Treatment of Amenorrhea from the Heart and Spleen
- Research Progress of Traditional Chinese Medicine Maintenance Treatment for Ulcerative Colitis during Remission
- Discussion on the TCM Diagnosis and Treatment Ideas and Methods of Short Stature from the Theory of “Spleen-Liver-Kidney Correlation”